HRT Financial’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

HRT Financial’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$553K	Buy	+8,348	New	+$489K	﹤0.01%	2572
2015 Q3	–	Sell	-10,200	Closed	-$635K	–	198
2015 Q2	$635K	Buy	+10,200	New	+$636K	0.3%	46

Other funds holding XPH

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.28% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Evelyn Partners London $46.9B AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

HRT Financial's XPH Position: Q2 2026 in Review

HRT Financial opened a new position in State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2026: 8,348 shares worth $553K. The stake represents ﹤0.01% of the portfolio and ranks #2572 among its holdings. This is a return to the name: HRT Financial previously reported a position in XPH as recently as Q2 2015.

HRT Financial first reported a position in XPH in Q2 2015 and has held it in 2 quarters since. The position peaked at $635K in Q2 2015. 92 funds tracked by Wall St. Rank hold XPH as of Q2 2026.

HRT Financial held 8,348 shares of State Street SPDR S&P Pharmaceuticals ETF worth $553K as of Q2 2026.
State Street SPDR S&P Pharmaceuticals ETF was a new HRT Financial position in Q2 2026.
State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #2572 holding.
HRT Financial first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2015 and has held it in 2 quarters since.
HRT Financial's State Street SPDR S&P Pharmaceuticals ETF position peaked at $635K in Q2 2015.
92 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.